Could a simple painkiller save lives after a torn aorta?

NCT ID NCT06968806

Recruiting now Disease control Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Source: ClinicalTrials.gov ↗

First seen Nov 17, 2025 · Last updated May 23, 2026 · Updated 24 times

Summary

This study tests whether the anti-inflammatory painkiller ketorolac can improve outcomes for 360 people undergoing emergency surgery for a severe tear in the main artery from the heart (Stanford Type A aortic dissection). Participants receive either ketorolac or a placebo before and after surgery, alongside standard care. Researchers will track deaths, organ failure, and other serious complications for up to 90 days to see if the drug helps control inflammation and improves recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Nanjing Drum Tower Hospital
RECRUITING

Nanjing, Jiangsu, 210008, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

AORTIC DISSECTION INFLAMMATION